<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Caring Sci</journal-id><journal-id journal-id-type="iso-abbrev">J Caring Sci</journal-id><journal-id journal-id-type="publisher-id">J Caring Sci</journal-id><journal-id journal-id-type="pmc">JCS</journal-id><journal-id journal-id-type="publisher-id">TBZMED</journal-id><journal-title-group><journal-title>Journal of Caring Sciences</journal-title></journal-title-group><issn pub-type="epub">2251-9920</issn><issn-l>2251-9920</issn-l><publisher><publisher-name>Tabriz University of Medical Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26989667</article-id><article-id pub-id-type="pmc">4794546</article-id><article-id pub-id-type="doi">10.15171/jcs.2016.007</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of Combined Use of Calcium and Vitamin B6 on Premenstrual Syndrome
Symptoms: a Randomized Clinical Trial</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Masoumi</surname><given-names>Seyedeh Zahra</given-names></name><xref ref-type="aff" rid="A01">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Ataollahi</surname><given-names>Maryam</given-names></name><xref ref-type="aff" rid="A02">
<sup>2</sup>
</xref><xref rid="COR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Oshvandi</surname><given-names>Khodayar</given-names></name><xref ref-type="aff" rid="A03">
<sup>3</sup>
</xref></contrib></contrib-group><aff id="A01"><sup>1</sup>Mother and Child Care Research Center, Department of Midwifery, Faculty of
Nursing and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran</aff><aff id="A02"><sup>2</sup>Department of Midwifery, Faculty of Nursing and Midwifery, Hamadan University of
Medical Sciences, Hamadan, Iran</aff><aff id="A03"><sup>3</sup>Mother and Child Care Research Center, Department of Nursing, Faculty of Nursing
and Midwifery, Hamadan University of Medical Sciences, Hamadan, Iran</aff><author-notes><corresp id="COR1"><label>*</label>Corresponding Author: Maryam Ataollahi (MSc),
email:<email>maryam.ataollahi@ymail.com</email> This clinical trial is registered on the
site plan No: IRCT2014070313405N3. </corresp></author-notes><pub-date pub-type="collection"><month>3</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>01</day><month>3</month><year>2016</year></pub-date><volume>5</volume><issue>1</issue><fpage>67</fpage><lpage>73</lpage><history><date date-type="received"><day>17</day><month>6</month><year>2015</year></date><date date-type="accepted"><day>18</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2016 by The Author(s)</copyright-statement><copyright-year>2016</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/" license-type="open-access"><license-p>This work is published by Journal of Caring Sciences as an open access article
distributed under the terms of the Creative Commons Attribution License
(<uri xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</uri>). Non-commercial uses of
the work are permitted, provided the original work is properly cited. </license-p></license></permissions><self-uri xlink:href="http://journals.tbzmed.ac.ir/JCS">http:// journals.tbzmed.ac.ir/
JCS</self-uri><abstract><p>
<bold><italic>Introduction:</italic></bold> Premenstrual syndrome is one of the most
common disorders in women, which includes a group of psychological and physical symptoms.
The aim of this study was to examine the impact of combined use of calcium and vitamin B6
on premenstrual syndrome symptoms. </p><p>
<bold><italic>Methods:</italic></bold> This double blind randomized controlled was carried
out on 76 students of Hamadan University of Medical Sciences. Students were randomly
allocated to two groups. (38 people in each group). Student in intervention groups
received calcium tablet (500mg) and vitamin B6 (40 mg) and student in intervention groups
received only vitamin B6 twice a day for two consecutive months. The symptoms were
assessed by Beck depression inventory (BDI) and daily symptom records (DSR)
questionnaires. Analyses were carried out by test-retest method, Chi-square, Mann-Whitney,
Independent t-test, and paired t-test using SPSS software ver.13.</p><p>
<bold><italic>Results</italic></bold> The result showed that although the severity of
symptoms decreased in both groups, but this reduction was more significant in the combined
calcium and vitamin B6 group.</p><p>
<bold><italic>Conclusion:</italic></bold> According to the result, using of combination of
calcium and vitamin B6 leads to better controlling of the premenstrual syndrome symptoms.
Therefore it is recommended for women who suffer from these syndromes.</p></abstract><kwd-group><kwd>Premenstrual syndrome</kwd><kwd>Calcium</kwd><kwd>Vitamin B6</kwd><kwd>Menstrual cycle</kwd></kwd-group><counts><fig-count count="1"/><table-count count="4"/><ref-count count="26"/><page-count count="7"/></counts></article-meta><notes><p> Please cite this paper as: Masoumi SZ, Ataollahi M, Oshvandi Kh. Effect of combined use of
calcium and vitamin b6 on premenstrual syndrome symptoms. J Caring Sci 2016; 5 (1):
67-73.doi:<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.15171/jcs.2016.007">
10.15171/jcs.2016.007</ext-link>.</p></notes></front><body><sec sec-type="introduction" id="s1"><title>Introduction</title><p> Premenstrual syndrome (PMS) is characterized by the presence of physical and psychological
symptoms occurring during the late luteal phase of the menstrual cycle and associated with
substantial impairment in social relationships&#x0200f;, lifestyle, and school
performance&#x0200f;.<sup><xref rid="R1" ref-type="bibr">1</xref>-<xref rid="R2" ref-type="bibr">2</xref></sup> It includes numerous psychological symptoms such as tension, anxiety,
crying, irritability, depression, hypersensitivity, poor concentration, fatigue, mood
swings, and anger. There are also physical symptoms including breast tenderness, abdominal
cramps, bloating, swelling, acne, increased appetite, headache, backache, and sleep
disturbance&#x0200f;.<sup><xref rid="R3" ref-type="bibr">3</xref></sup> Although the
pathophysiology of PMS is not well known, the interactions between ovarian hormones and
neurotransmitters, mineral and vitamin (vitamins B6 and calcium) deficiency, and reduced
serotonin level are likely to play a role in the etiology of the disorder&#x0200f;.<sup><xref rid="R4" ref-type="bibr">4</xref>-<xref rid="R5" ref-type="bibr">5</xref></sup> The
exact prevalence of this syndrome is unknown<sup><xref rid="R6" ref-type="bibr">6</xref></sup>, but epidemiological surveys have estimated that as many as 85% of women
at their reproductive age experience at least one symptom of premenstrual syndrome<sup><xref rid="R7" ref-type="bibr">7</xref>,<xref rid="R8" ref-type="bibr">8</xref></sup> and
2.5&#x02013;3% of women suffer from the severe form of PMS, known as premenstrual dysphonic disorder
(PMDD)&#x0200f;.<sup><xref rid="R9" ref-type="bibr">9</xref></sup></p><p> Therapeutic interventions for the premenstrual syndrome range from nonpharmacological
management to psychotropic medications and hormonal therapy, oral contraceptives, selective
serotonin reuptake inhibitors &#x0200f;)SSRIs&#x0200f;(, and SNRIs as well as GnRH agonists&#x0200f;.<sup><xref rid="R10" ref-type="bibr">10</xref>-<xref rid="R13" ref-type="bibr">13</xref></sup>There
is no research directly addressing the effect of combined use of calcium and vitamin B6 on
PMS symptoms. But, various studies have been conducted on the positive effect of vitamin B6
or calcium on reducing PMS symptoms. In this regard, Alexander confirmed the effectiveness
of vitamin B6 on PMS&#x0200f;.<sup><xref rid="R14" ref-type="bibr">14</xref></sup> Also, Panay
Moayyed showed the positive effect of vitamin B6 on reducing PMS symptoms.<sup><xref rid="R4" ref-type="bibr">4</xref></sup>In other studies, positive effects of vitamin B6
for PMS symptoms have been shown&#x0200f;.<sup><xref rid="R15" ref-type="bibr">15</xref>-<xref rid="R16" ref-type="bibr">16</xref></sup></p><p> Pourmohsen et al., demonstrated the positive effect of calcium and vitamin E on reducing
PMS symptoms&#x0200f;.<sup><xref rid="R17" ref-type="bibr">17</xref></sup> Sutariya et al., reported
the positive effect of the intake of calcium on reducing PMS symptom.<sup><xref rid="R18" ref-type="bibr">18</xref></sup></p><p> Ghanbari et al., indicated the positive effect of calcium on mitigating the physical and
psychological symptoms&#x0200f;.<sup><xref rid="R5" ref-type="bibr">5</xref></sup>Since separately
taking calcium and vitamin B6 reduces the severity of PMS, it seems that using the
combination of calcium and vitamin B6 might be more effective in reducing the symptoms of
premenstrual syndrome. Therefore, this study was aimed to examine the impact of combined use
of calcium and vitamin B6 on premenstrual syndrome symptoms.</p></sec><sec sec-type="materials and methods" id="s2"><title>Materials and methods</title><p> This study was a double blind randomized controlled clinical trial carried out in Hamadan
University of Medical Sciences in 2015. The sample size was estimated using the following
formula&#x0200f;: N = (Z<sub>&#x003b1;/2</sub> + Z<sub>&#x003b2;</sub>) 2&#x003c3;<sub> 2</sub>) / &#x003b5;<sub>2</sub>. With 95%
confidence interval, the minimum sample size of 76 participants was determined. Out of 312
students who were assessed, 130 people meet the following inclusion criteria: 20-30 years of
age; regular menstrual periods with 21-35 days of cycles and 3-10 days of bleeding period;
no known mental illnesses; no physical illnesses such as diabetes, seizure disorders,
hypothyroidism, and so on; no death of close relatives; divorce or other adverse events
during the last three months; no surgery in the three months before entering the study; and
no use of antidepressants, hormonal contraceptives, medroxy progesterone acetate, and
vitamins in the past three months. The students were excluded from the research in the case
of pregnancy, incidents like death of close relatives, divorce, and other adverse events.
Data collection tools included demographic data, Beck depression inventory (BDI), and daily
symptom records (DSR). At the first stage, the participants filled out Beck depression
inventory. If they got the score of 1-10, they entered the study.</p><p> Then, the demographic questionnaire was presented to them. Daily symptom records were
completed by the students to confirm PMS diagnosis and they were informed about how to
complete the questionnaires. The participants recorded daily symptoms score with numbers 0
(no), 1 (mild), 2 (moderate), and 3 (severe). The mean score of the symptoms was calculated
from 1 week prior to the menstrual period to 5 days afterwards. Total score of the symptoms
of headache, breast tenderness, acne, swelling, bloating, and palpitations demonstrated the
severity of physical symptoms and total score of the symptoms of irritability, tension,
sleep problems, mood swings, food cravings, wish to be alone, depression, forgetfulness,
anxiety, poor concentration, crying, suicide, decreased libido, and fatigue showed the
severity of psychological symptoms. The questionnaires were collected after two months.
Totally, 109 students filled out and returned the questionnaire, based on which the
diagnosis of premenstrual syndrome was confirmed in 81 students. Out of these 81 students, 5
refused to participate and 76 entered the study. They were then divided into two groups
using the table of random numbers; 38 in the intervention and 38 in the control groups
(<xref ref-type="fig" rid="F1">Figure 1</xref>). Student in intervention groups received
calcium tablet (500 mg) and vitamin B6 (40 mg) and student in intervention groups received
only vitamin B6 twice a day in the, between the 16<sup>th</sup> days of the menstrual cycle
to the 5<sup>th</sup> day of the next menstrual period for two consecutive months. Validity
of BDI and DSR questionnaires was confirmed through content validity and test-retest method
was used to assess their reliability (r = 0.89, 0.82 respectively). DSR questionnaire has
been standardized worldwide and its validity and reliability has been confirmed in previous
studies&#x0200f;.<sup><xref rid="R19" ref-type="bibr">19</xref>-<xref rid="R21" ref-type="bibr">21</xref></sup>BDI is also a global standard questionnaire which its validity and
reliability has been confirmed in various studies&#x0200f;.<sup><xref rid="R20" ref-type="bibr">20</xref>,<xref rid="R22" ref-type="bibr">22</xref>-<xref rid="R23" ref-type="bibr">23</xref></sup>. The data was analyzed using SPSS software ver.13 by following tests:
test-retest method, Chi-square, Mann-Whitney, Independent t-test, paired t-test. The
significance level was assumed to be P&#x0003c;0.05.</p><p> This double blind clinical trial was approved by Ethics Committee of Hamadan University of
Medical Sciences. Also, a written consent form was taken from the students. We also assured
the confidentiality of all participants.</p><fig id="F1" orientation="portrait" position="float"><label>Figure 1</label><graphic xlink:href="jcs-5-67-g001"/><statement><p>Consort flow chart</p></statement></fig></sec><sec sec-type="results" id="s3"><title>Results</title><p> In this clinical trial, 132 students were eligible and finally 76 students were included
in the study (<xref ref-type="fig" rid="F1">Figure 1</xref>). The results showed that the
two groups were similar in terms of demographic characteristics. The mean (SD) age of study
samples in the intervention (calcium and vitamin B6) and control (vitamin B6 alone) groups
was 20.78 (1.23) and 21.23 (2.89) respectively. The mean (SD) of BMI in intervention and
control group was 20.46 (2.76) and 21.58 (2.20), respectively (<xref ref-type="table" rid="T1">Table 1</xref>). The history of premenstrual syndrome in the intervention and
control group was 71.05% and 60.52%, respectively. The mean score of physical symptoms were
significantly reduced in intervention group compared to control group 0.25 (0.15) vs. 0.42
(0.46) (P=0.03) (<xref ref-type="table" rid="T2">Table 2</xref>). As well as the mean score
of psychological symptoms was decreased in intervention group compared to control group 0.26
(0.21) vs. 0.47 (0.37) with significant differences (P=0.003) (<xref ref-type="table" rid="T3">Table 3</xref>). Also, the mean score of general symptoms were decreased in
intervention group compared to control group 0.25 (0.17) vs. 0.44 (0.32) (P=0.002) (<xref ref-type="table" rid="T4">Table 4</xref>). The mean score of physical, psychological and
general symptoms in intervention group were significantly reduced, but within control group
just psychological and general symptoms were significantly reduced after receiving
drugs.</p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Comparison of demographic characteristics in both groups</title></caption><table frame="hsides" rules="groups"><tbody><tr><td style="text-align: center; border-style: solid none none none; border-width: 1px" rowspan="1" colspan="1">
</td><td colspan="3" style="text-align: center; border-style: solid none none none; border-width: 1px" rowspan="1">
<bold> Treatment categories</bold>
</td></tr><tr><td style="border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>Variable</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>Calcium and vitamin B6</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>Vitamin B6</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>P</bold>
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Age</bold>
<sup>*</sup>(years)</td><td style="text-align: center" rowspan="1" colspan="1">20.78 (1.23)</td><td style="text-align: center" rowspan="1" colspan="1">21.23 (2.89)</td><td style="text-align: center" rowspan="1" colspan="1">0.34</td></tr><tr><td rowspan="1" colspan="1">
<bold>Age of menarche</bold>
<sup>*</sup>(years)</td><td style="text-align: center" rowspan="1" colspan="1">13.31 (1.16)</td><td style="text-align: center" rowspan="1" colspan="1">12.31 (1.29)</td><td style="text-align: center" rowspan="1" colspan="1">0.09</td></tr><tr><td rowspan="1" colspan="1">
<bold>BMI</bold>
<sup>*</sup>(kg/m&#x000b2;)</td><td style="text-align: center" rowspan="1" colspan="1"> 20.46 (2.76)</td><td style="text-align: center" rowspan="1" colspan="1">21.58 (2.20)</td><td style="text-align: center" rowspan="1" colspan="1">0.05</td></tr><tr><td rowspan="1" colspan="1">
<bold>Education level</bold>
<sup>**</sup>
</td><td style="text-align: center" rowspan="1" colspan="1">
</td><td style="text-align: center" rowspan="1" colspan="1">
</td><td style="text-align: center" rowspan="1" colspan="1">0.21</td></tr><tr><td style="padding-left: 30px" rowspan="1" colspan="1">&#x0003c;(bachelor)</td><td style="text-align: center" rowspan="1" colspan="1">86.84</td><td style="text-align: center" rowspan="1" colspan="1">78.94</td><td style="text-align: center" rowspan="1" colspan="1">
</td></tr><tr><td style="padding-left: 30px" rowspan="1" colspan="1">&#x0003e;(bachelor)</td><td style="text-align: center" rowspan="1" colspan="1">13.15</td><td style="text-align: center" rowspan="1" colspan="1">21.05</td><td style="text-align: center" rowspan="1" colspan="1">
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Marital status</bold>
<sup>**</sup>
</td><td style="text-align: center" rowspan="1" colspan="1">
</td><td style="text-align: center" rowspan="1" colspan="1">
</td><td style="text-align: center" rowspan="1" colspan="1">0.23</td></tr><tr><td style="padding-left: 30px" rowspan="1" colspan="1">Single</td><td style="text-align: center" rowspan="1" colspan="1">76.31</td><td style="text-align: center" rowspan="1" colspan="1">86.84</td><td style="text-align: center" rowspan="1" colspan="1">
</td></tr><tr><td style="padding-left: 30px; border-style: none none solid none; border-width: 1px" rowspan="1" colspan="1">Married</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">23.68</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">13.15</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>*</sup>Mean (SD),<sup>**</sup>Value isPercent</p></fn></table-wrap-foot></table-wrap><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Comparison of mean score severity of physical symptoms premenstrual syndrome before
and after the intervention in both groups</title></caption><table frame="hsides" rules="groups"><tbody><tr><td style="text-align: center; border-style: solid none none none; border-width: 1px" rowspan="1" colspan="1">
</td><td colspan="3" style="text-align: center; border-style: solid none none none; border-width: 1px" rowspan="1">
<bold>Physical symptoms</bold>
</td></tr><tr><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>Treatment round groups</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>Before treatment</bold>
<break/>
<bold>Mean (SD)</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>8 Weeks after treatment</bold>
<break/>
<bold>Mean (SD)</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>P</bold>
<sup>*</sup>
<break/>
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Calcium and Vitamin B6 </bold>
</td><td style="text-align: center" rowspan="1" colspan="1">0.57 (0.31)</td><td style="text-align: center" rowspan="1" colspan="1">0.25 (0.15)</td><td style="text-align: center" rowspan="1" colspan="1">0.00</td></tr><tr><td rowspan="1" colspan="1">
<bold>Vitamin B6</bold>
</td><td style="text-align: center" rowspan="1" colspan="1">0.53 (0.33)</td><td style="text-align: center" rowspan="1" colspan="1">0.42 (0.46)</td><td style="text-align: center" rowspan="1" colspan="1">0.21</td></tr><tr><td style="border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>P</bold>
<sup>**</sup>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">0.627</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">0.030</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>*</sup>Paired t-test, <sup>**</sup> t-test</p></fn></table-wrap-foot></table-wrap><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Comparison of mean score severity of psychological symptoms premenstrual syndrome
before and after the intervention in both groups</title></caption><table frame="hsides" rules="groups"><tbody><tr><td style="text-align: center; border-style: solid none none none; border-width: 1px" rowspan="1" colspan="1">
</td><td colspan="3" style="text-align: center; border-style: solid none none none; border-width: 1px" rowspan="1">
<bold>Psychological symptoms</bold>
</td></tr><tr><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>Treatment round groups</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>Before treatment</bold>
<break/>
<bold>Mean (SD)</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>8 weeks after treatment</bold>
<break/>
<bold>Mean (SD)</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>P</bold>
<sup>*</sup>
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Calcium and Vitamin B6</bold>
</td><td style="text-align: center" rowspan="1" colspan="1">0.74 (0.37)</td><td style="text-align: center" rowspan="1" colspan="1">0.26 (0.21)</td><td style="text-align: center" rowspan="1" colspan="1">0.000</td></tr><tr><td rowspan="1" colspan="1">
<bold>Vitamin B6</bold>
</td><td style="text-align: center" rowspan="1" colspan="1">0.61 (0.36)</td><td style="text-align: center" rowspan="1" colspan="1">0.47 (0.37)</td><td style="text-align: center" rowspan="1" colspan="1">0.017</td></tr><tr><td style="border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>P</bold>
<sup>**</sup>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">0.112</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">0.003</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>*</sup>Paired t-test, <sup>**</sup> t-test</p></fn></table-wrap-foot></table-wrap><table-wrap id="T4" orientation="portrait" position="float"><label>Table 4</label><caption><title>Comparison of mean score severity of general symptoms premenstrual syndrome before
and after the intervention in both groups</title></caption><table frame="hsides" rules="groups"><tbody><tr><td style="text-align: center; border-style: solid none none none; border-width: 1px" rowspan="1" colspan="1">
</td><td colspan="3" style="text-align: center; border-style: solid none none none; border-width: 1px" rowspan="1">
<bold>General symptoms</bold>
</td></tr><tr><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>Treatment round groups</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>Before treatment</bold>
<break/>
<bold>Mean (SD)</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>8 weeks after treatment</bold>
<break/>
<bold>Mean (SD)</bold>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>P</bold>
<sup>*</sup>
<break/>
</td></tr><tr><td rowspan="1" colspan="1">
<bold>Calcium and Vitamin B6</bold>
</td><td style="text-align: center" rowspan="1" colspan="1">0.72 (0.33)</td><td style="text-align: center" rowspan="1" colspan="1">0.25 (0.17)</td><td style="text-align: center" rowspan="1" colspan="1">0.000</td></tr><tr><td rowspan="1" colspan="1">
<bold>Vitamin B6</bold>
</td><td style="text-align: center" rowspan="1" colspan="1">0.61 (0.35)</td><td style="text-align: center" rowspan="1" colspan="1">0.44 (0.32)</td><td style="text-align: center" rowspan="1" colspan="1">0.007</td></tr><tr><td style="border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
<bold>P</bold>
<sup>**</sup>
<bold/>
</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">0.16</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">0.002</td><td style="text-align: center; border-style: none none solid none; border-width: 1px;" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>*</sup>Paired t-test, <sup>**</sup> t-test</p></fn></table-wrap-foot></table-wrap></sec><sec sec-type="discussion" id="s4"><title>Discussion</title><p> The results showed that although the score of overall symptoms of premenstrual syndrome in
the two groups decreased, this reduction was significantly greater in the group taking
combined calcium and vitamin B6. In our study physical symptoms of PMS have been decreased
by using a combination of vitamin and calcium. In Pourmohsen's study in 2010 in Tehran,
combined administration of calcium and vitamin E resulted in 56% reduction of the overall
symptoms in premenstrual syndrome&#x0200f;.<sup><xref rid="R17" ref-type="bibr">17</xref></sup>
Also, Sutaria demonstrated that daily use of 500 mg calcium led to 75% reduction of overall
symptoms of PMS after three months of treatment.<sup><xref rid="R18" ref-type="bibr">18</xref></sup> In another study daily use of 600 mg calcium resulted in 48% reduction
of physical symptoms in the intervention group.<sup><xref rid="R24" ref-type="bibr">24</xref></sup> other study conducted by Kashanian in 2007 showed that using of vitamin
B6 for two consecutive cycles decreased some of the physical symptoms such as edema,
bloating, and heart palpitations.<sup><xref rid="R25" ref-type="bibr">25</xref></sup></p><p> The results of our study indicated that the reduction in psychological symptoms have been
reduced in the students treated with combined calcium and vitamin B6. Vitamin B and calcium
plays an essential role in the regulation of mood, psychological imbalances, particularly
symptoms of depression. This effect is related to the production of serotonin and tryptophan
metabolism.<sup><xref rid="R26" ref-type="bibr">26</xref></sup> In a study there has
been 48 percent reduction in psychiatric symptoms with a daily intake of 600 mg of
calcium.<sup><xref rid="R17" ref-type="bibr">17</xref></sup></p><p> In the study by Chou in 2008, the positive effect of B vitamins on reducing psychological
symptoms such as stress, anxiety, crying offense, fatigue, insomnia, and forgetfulness was
mentioned.<sup><xref rid="R16" ref-type="bibr">16</xref></sup></p><p> Moreover, Kashanian in 2007 found that the use of 80 mg vitamin B6 for two consecutive
cycles decreased some of the mental symptoms, including irritability, anxiety, crying for no
reason, forgetfulness, and tendency to eat sweets&#x0200f;.<sup><xref rid="R25" ref-type="bibr">25</xref></sup> Also, Ghanbari evaluated the effect of calcium supplementation on the
symptoms of premenstrual syndrome and demonstrated that the daily use of 500 mg calcium for
three consecutive cycles could reduce the psychological symptoms including fatigue,
depression, and appetite changes.<sup><xref rid="R5" ref-type="bibr">5</xref></sup>In
another study, combined administration of calcium and vitamin E had positive effect on the
reduction of some psychological symptoms including withdrawal from social
relationships.<sup><xref rid="R17" ref-type="bibr">17</xref></sup>The results of the
above studies have been consistent with our results. Due to the positive effect of combined
use of calcium and vitamin B6 on the symptoms of PMS, the use of this supplement is
recommended to reduce the symptoms of this syndrome.</p></sec><sec sec-type="conclusion" id="s5"><title>Conclusion</title><p> This study showed that combined use of calcium and vitamin B6 significantly reduced the
symptoms of premenstrual syndrome as compared with vitamin B6 alone. It seems that the
combination of calcium and vitamin B6 can be used for better controlling of the premenstrual
syndrome symptoms. Since few studies have been done in this area, further studies and
comparison the effect of these drugs with other chemical drugs are recommended. Based on the
results obtained in this study, midwives and gynecologists can administer the combined use
of calcium and vitamin B6 for the patients with premenstrual syndrome.</p><p> This study was conducted on the students of Hamadan University of Medical Sciences who
might not be the representative of all the women; thus, the results cannot be generalized to
all the women at the reproductive age.</p></sec><sec id="s6"><title>Acknowledgments</title><p> The authors would like to thank the Vice-Chancellor of Research and Technology, Hamadan
University of Medical Sciences, which approved and financially supported this project. They
would also like to thank all the students who participated in this study for their
cooperation.</p></sec><sec id="s7"><title>Ethical issues</title><p> None to be declared.</p></sec><sec id="s8"><title>Conflict of interest</title><p> The authors declare no conflict of interest in this study&#x0200f;.</p></sec></body><back><ref-list><title>References</title><ref id="R1"><label>1</label><element-citation publication-type="journal"><name><surname>Cheng</surname><given-names>SH</given-names></name><name><surname>Shih</surname><given-names>CC</given-names></name><name><surname>Yang</surname><given-names>YK</given-names></name><name><surname>Chen</surname><given-names>KT</given-names></name><name><surname>Chang</surname><given-names>YH</given-names></name><name><surname>Yang</surname><given-names>YC</given-names></name><article-title>Factors associated with premenstrual syndrome&#x02014;A survey of new female
university students</article-title><source>Kaohsiung J Med Sci</source><year>2013</year><volume>29</volume><issue>2</issue><fpage>100</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1016/j.kjms.2012.08.017</pub-id><pub-id pub-id-type="pmid">23347812</pub-id></element-citation></ref><ref id="R2"><label>2</label><element-citation publication-type="journal"><name><surname>Zaka</surname><given-names>M</given-names></name><name><surname>Mahmood</surname><given-names>KT</given-names></name><article-title>Pre-menstrual syndrome-a review</article-title><source>Journal of Pharmaceutical Sciences &#x00026; Research</source><year>2012</year><volume>4</volume><issue>1</issue><fpage>1684</fpage><lpage>91</lpage></element-citation></ref><ref id="R3"><label>3</label><element-citation publication-type="journal"><name><surname>Delaram</surname><given-names>M</given-names></name><name><surname>Jafari</surname><given-names>F</given-names></name><article-title>The effect of fennel on the premenstrual syndrome</article-title><source>Knowledge and Health Journal</source><year>2011</year><volume>6</volume><issue>1</issue><fpage>1</fpage><lpage>6</lpage></element-citation></ref><ref id="R4"><label>4</label><element-citation publication-type="journal"><name><surname>Panay</surname><given-names>N</given-names></name><article-title>Management of premenstrual syndrome</article-title><source>J Fam Plann Reprod Health Care</source><year>2009</year><volume>35</volume><issue>3</issue><fpage>187</fpage><lpage>94</lpage><pub-id pub-id-type="doi">10.1783/147118909788708147</pub-id><pub-id pub-id-type="pmid">19622211</pub-id></element-citation></ref><ref id="R5"><label>5</label><element-citation publication-type="journal"><name><surname>Ghanbari</surname><given-names>Z</given-names></name><name><surname>Haghollahi</surname><given-names>F</given-names></name><name><surname>Shariat</surname><given-names>M</given-names></name><name><surname>Foroshani</surname><given-names>AR</given-names></name><name><surname>Ashrafi</surname><given-names>M</given-names></name><article-title>Effects of calcium supplement therapy in women with premenstrual
syndrome</article-title><source>Taiwan J Obstet Gynecol</source><year>2009</year><volume>48</volume><issue>2</issue><fpage>124</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1016/S1028-4559(09)60271-0</pub-id><pub-id pub-id-type="pmid">19574172</pub-id></element-citation></ref><ref id="R6"><label>6</label><element-citation publication-type="journal"><name><surname>Braverman</surname><given-names>PK</given-names></name><article-title>Premenstrual syndrome and premenstrual dysphoric disorder</article-title><source>J Pediatr Adolesc Gynecol</source><year>2007</year><volume>20</volume><issue>1</issue><fpage>3</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1016/j.jpag.2006.10.007</pub-id><pub-id pub-id-type="pmid">17289510</pub-id></element-citation></ref><ref id="R7"><label>7</label><element-citation publication-type="journal"><name><surname>Seedhom</surname><given-names>AE</given-names></name><name><surname>Mohammed</surname><given-names>ES</given-names></name><name><surname>Mahfouz</surname><given-names>EM</given-names></name><article-title>Life Style Factors Associated with Premenstrual Syndrome among El-Minia
University Students, Egypt</article-title><source>Int Sch Res Notices</source><year>2013</year><volume>2013</volume><issue>2013</issue><pub-id pub-id-type="doi">10.1155/2013/617123</pub-id></element-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="other"> Kroll AR.
Recreational physical activity and premenstrual syndrome in college-aged women. [Master&#x02019;s
thesis]. 2010. Massachusetts: University of Massachusetts Amherst. </mixed-citation></ref><ref id="R9"><label>9</label><element-citation publication-type="journal"><name><surname>Milewicz</surname><given-names>A</given-names></name><name><surname>Jedrzejuk</surname><given-names>D</given-names></name><article-title>Premenstrual syndrome: from etiology to treatment</article-title><source>Maturitas</source><year>2006</year><volume>55</volume><fpage>S47</fpage><lpage>S54</lpage><pub-id pub-id-type="doi">10.1016/j.maturitas.2006.06.016</pub-id></element-citation></ref><ref id="R10"><label>10</label><element-citation publication-type="journal"><name><surname>Potter</surname><given-names>J</given-names></name><name><surname>Bouyer</surname><given-names>J</given-names></name><name><surname>Trussell</surname><given-names>J</given-names></name><name><surname>Moreau</surname><given-names>C</given-names></name><article-title>Premenstrual syndrome prevalence and fluctuation over time: results from a
French population-based survey</article-title><source>Journal of Women's Health</source><year>2009</year><volume>18</volume><issue>1</issue><fpage>31</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1089/jwh.2008.0932</pub-id></element-citation></ref><ref id="R11"><label>11</label><element-citation publication-type="journal"><name><surname>Zukov</surname><given-names>I</given-names></name><name><surname>Pt&#x000e1;cek</surname><given-names>R</given-names></name><name><surname>Raboch</surname><given-names>J</given-names></name><name><surname>Domluvilov&#x000e1;</surname><given-names>D</given-names></name><name><surname>Kuzelov&#x000e1;</surname><given-names>H</given-names></name><name><surname>Fischer</surname><given-names>S</given-names></name><etal/><article-title>Premenstrual dysphoric disorder&#x02014;review of actual findings about mental
disorders related to menstrual cycle and possibilities of their therapy</article-title><source>Prague Med Rep</source><year>2010</year><volume>111</volume><issue>1</issue><fpage>12</fpage><lpage>24</lpage></element-citation></ref><ref id="R12"><label>12</label><element-citation publication-type="journal"><name><surname>Cunningham</surname><given-names>J</given-names></name><name><surname>Yonkers</surname><given-names>KA</given-names></name><name><surname>O'Brien</surname><given-names>S</given-names></name><name><surname>Eriksson</surname><given-names>E</given-names></name><article-title>Update on research and treatment of premenstrual dysphoric
disorder</article-title><source>Harv Rev Psychiatry</source><year>2009</year><volume>17</volume><issue>2</issue><fpage>120</fpage><lpage>137</lpage><pub-id pub-id-type="doi">10.1080/10673220902891836</pub-id><pub-id pub-id-type="pmid">19373620</pub-id></element-citation></ref><ref id="R13"><label>13</label><element-citation publication-type="journal"><name><surname>Biggs</surname><given-names>WS</given-names></name><name><surname>Demuth</surname><given-names>RH</given-names></name><article-title>Premenstrual syndrome and premenstrual dysphoric disorder</article-title><source>Am Fam Physician</source><year>2011</year><volume>84</volume><issue>8</issue><fpage>918</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">22010771</pub-id></element-citation></ref><ref id="R14"><label>14</label><element-citation publication-type="book"><name><surname>Alexander</surname><given-names>L</given-names></name><source>Natural wellness strategies for the menopause years: natural wellness strategies
for women (women's wisdom)</source><year>2012</year><publisher-loc>Scotland</publisher-loc><publisher-name>Findhorn Press</publisher-name></element-citation></ref><ref id="R15"><label>15</label><element-citation publication-type="journal"><name><surname>Sabet-Birjandi</surname><given-names>S</given-names></name><name><surname>Tadayon-Najafabadi</surname><given-names>M</given-names></name><name><surname>Siyahpooshan</surname><given-names>A</given-names></name><name><surname>Haghighizadeh</surname><given-names>M</given-names></name><article-title>Comparision the effect of hypericum perforatum and vitamin B6 in the
treatment of premenstrual syndrome</article-title><source>Zahedan Journal of Research in Medical Sciences</source><year>2011</year><volume>13</volume><issue>4</issue><fpage>1</fpage><lpage>5</lpage></element-citation></ref><ref id="R16"><label>16</label><element-citation publication-type="journal"><name><surname>Chou</surname><given-names>PB</given-names></name><name><surname>Morse</surname><given-names>CA</given-names></name><name><surname>Xu</surname><given-names>H</given-names></name><article-title>A controlled trial of Chinese herbal medicine for premenstrual
syndrome</article-title><source>J Psychosom Obstet Gynaecol</source><year>2008</year><volume>29</volume><issue>3</issue><fpage>189</fpage><lpage>96</lpage><pub-id pub-id-type="doi">10.1080/01674820801893011</pub-id></element-citation></ref><ref id="R17"><label>17</label><element-citation publication-type="journal"><name><surname>Pourmohsen</surname><given-names>M</given-names></name><name><surname>Zounemat</surname><given-names>KA</given-names></name><name><surname>Taavoni</surname><given-names>S</given-names></name><name><surname>Hosseini</surname><given-names>AF</given-names></name><article-title>Effect of combined calcium and vitamin E consumption on premenstrual
syndrome</article-title><source>Iran Journal of Nursing</source><year>2010</year><volume>23</volume><issue>65</issue><fpage>8</fpage><lpage>14</lpage><comment>(Persian&#x0200f;)</comment></element-citation></ref><ref id="R18"><label>18</label><element-citation publication-type="journal"><name><surname>Sutariya</surname><given-names>S</given-names></name><name><surname>Talsania</surname><given-names>N</given-names></name><name><surname>Shah</surname><given-names>C</given-names></name><name><surname>Patel</surname><given-names>M</given-names></name><article-title>An interventional study (calcium supplementation and health education) on
premenstrual syndrome-effect on premenstrual and menstrual symptoms</article-title><source>National Journal of Community Medicine</source><year>2011</year><volume>2</volume><issue>1</issue><fpage>100</fpage><lpage>4</lpage></element-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="other"> Chocano-
Bedoya PO. Micronutrient intake and premenstrual syndrome. [Dissertations]. Massachusetts:
University of Massachusetts &#x02013; Amherst. 2011. </mixed-citation></ref><ref id="R20"><label>20</label><element-citation publication-type="journal"><name><surname>Suija</surname><given-names>K</given-names></name><name><surname>Rajala</surname><given-names>U</given-names></name><name><surname>Jokelainen</surname><given-names>J</given-names></name><name><surname>Jokelainen</surname><given-names>J</given-names></name><name><surname>Liukkonen</surname><given-names>T</given-names></name><name><surname>H&#x000e4;rk&#x000f6;nen</surname><given-names>P</given-names></name><etal/><article-title>Validation of the Whooley questions and the Beck&#x0200f; Depression Inventory in
older adults</article-title><source>Scand J Prim Health Care</source><year>2012</year><volume>30</volume><issue>4</issue><fpage>259</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.3109/02813432.2012.732473</pub-id><pub-id pub-id-type="pmid">23113732</pub-id></element-citation></ref><ref id="R21"><label>21</label><element-citation publication-type="book"><name><surname>Fritz</surname><given-names>MA</given-names></name><name><surname>Speroff</surname><given-names>L</given-names></name><source>Clinical gynecologic endocrinology and infertility</source><edition>8th ed</edition><year>2011</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>Lippincott Williams &#x00026; Wilkin</publisher-name></element-citation></ref><ref id="R22"><label>22</label><element-citation publication-type="journal"><name><surname>Singh</surname><given-names>N</given-names></name><name><surname>Verma</surname><given-names>P</given-names></name><name><surname>Pandey</surname><given-names>B</given-names></name><article-title>Therapeutic potential of organic triticum aestivum linn(Wheat grass) in
prevention and treatment of chronic diseases: an overview</article-title><source>International Journal of Pharmaceutical Sciences and Drug Research</source><year>2012</year><volume>4</volume><issue>1</issue><fpage>10</fpage><lpage>4</lpage></element-citation></ref><ref id="R23"><label>23</label><element-citation publication-type="journal"><name><surname>Seddigh</surname><given-names>R</given-names></name><name><surname>Shariat</surname><given-names>SV</given-names></name><name><surname>Gharraee</surname><given-names>B</given-names></name><name><surname>Azarnik</surname><given-names>S</given-names></name><article-title>Evaluation of relationship between severity of depression and chess skill
in members with international rating scale in chess federation of islamic republic of
Iran in 1389</article-title><source>Razi Journal of Medical Sciences</source><year>2012</year><volume>19</volume><issue>100</issue><fpage>29</fpage><lpage>36</lpage><comment>(Persian)</comment></element-citation></ref><ref id="R24"><label>24</label><element-citation publication-type="journal"><name><surname>Pearlstein</surname><given-names>T</given-names></name><name><surname>Steiner</surname><given-names>M</given-names></name><article-title>Premenstrual dysphoric disorder: burden of illness and treatment
update</article-title><source>Women's Mental Health</source><year>2012</year><volume>10</volume><issue>1</issue><fpage>90</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1176/appi.focus.10.1.90</pub-id></element-citation></ref><ref id="R25"><label>25</label><element-citation publication-type="journal"><name><surname>Kashanian</surname><given-names>M</given-names></name><name><surname>Mazinani</surname><given-names>R</given-names></name><name><surname>Jalalmanesh</surname><given-names>S</given-names></name><article-title>Pyridoxine (vitamin B6) therapy for premenstrual syndrome</article-title><source>Int J Gynaecol Obstet</source><year>2007</year><volume>96</volume><issue>1</issue><fpage>43</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.ijgo.2006.09.014</pub-id><pub-id pub-id-type="pmid">17187801</pub-id></element-citation></ref><ref id="R26"><label>26</label><element-citation publication-type="journal"><name><surname>Merete</surname><given-names>C</given-names></name><name><surname>Falcon</surname><given-names>LM</given-names></name><name><surname>Tucker</surname><given-names>KL</given-names></name><article-title>Vitamin B6 is associated with depressive&#x0200f; symptomatology in Massachusetts
elders</article-title><source>J Am Coll Nutr</source><year>2008</year><volume>27</volume><issue>3</issue><fpage>421</fpage><lpage>27</lpage><pub-id pub-id-type="pmid">18838531</pub-id></element-citation></ref></ref-list></back></article>